The impact of heart failure on the classification of COPD severity.

Abstract:

BACKGROUND:Pulmonary restriction-a reduction of lung volumes-is common in heart failure (HF), rendering severity grading of chronic obstructive pulmonary disease (COPD) potentially problematic in subjects with both diseases. We compared pulmonary function in patients with either HF or COPD, or the combination to assess whether grading of COPD using the Global Initiative of Chronic Obstructive Lung Disease classification is hampered in the presence of HF. METHODS AND RESULTS:In 2 cohorts involving 591 patients with established HF and 405 with a primary care diagnosis of COPD, the presence of HF and COPD was assessed according to guidelines. HF severity was staged according to the NYHA classification system into Classes I-IV. COPD was diagnosed if the ratio of post-bronchodilator forced expiratory volume in 1 second and forced vital capacity (FEV1/FVC) was <0.70, and categorized in GOLD stages I-IV according to post-bronchodilator-predicted FEV1 levels (FEV1% ≥80%; 50-79%; 30-49%; <30%). In total, 557 patients with HF only, 108 with HF+COPD, and 194 with COPD only were studied. Patients, who had neither HF nor COPD according to definition, or HF with reversible obstruction in post-bronchodilator pulmonary function tests were excluded from this analysis (n = 137). Compared with COPD only, patients with HF plus COPD had higher levels of post-bronchodilator FEV1/FVC (median [quartiles] 0.57 [0.47-0.64] vs 0.62 [0.55-0.66] and lower total lung capacity % (115 [104-126]% vs 105 [95-117]%, P < .001) P < .001), but comparable levels of post-bronchodilator FEV1% (70 [56-84]% vs 68 [54-80]%, P = .22) and thus similar distributions of GOLD stages I-IV in both groups (24/56/19/4% vs 31/50/19/1%, P = .57). In patients with HF only, 25% exhibited pre-bronchodilator FEV1% levels of <80% (FEV1% 94 [80-108]%), despite a pre-bronchodilator FEV/FVC ratio ≥0.7 in this group. The reduction of FEV1 in patients with HF only was associated with HF severity. CONCLUSIONS:In stable HF, FEV1 may be significantly reduced even in the absence of "real" airflow obstruction. In this situation, diagnosing COPD according to GOLD criteria (based on FEV1/FVC) still seems feasible, because both FEV1 and FVC are usually decreased to an equal extent in HF. However, classifying COPD based on FEV1 levels may overrate obstruction severity in patients with combined disease (HF plus COPD), and thus may lead to unjustified use of bronchodilators.

journal_name

J Card Fail

authors

Güder G,Rutten FH,Brenner S,Angermann CE,Berliner D,Ertl G,Jany B,Lammers JW,Hoes AW,Störk S

doi

10.1016/j.cardfail.2012.05.008

subject

Has Abstract

pub_date

2012-08-01 00:00:00

pages

637-44

issue

8

eissn

1071-9164

issn

1532-8414

pii

S1071-9164(12)00181-9

journal_volume

18

pub_type

杂志文章
  • Acute heart failure with and without concomitant acute coronary syndromes: patient characteristics, management, and survival.

    abstract:BACKGROUND:Acute coronary syndromes (ACS) may precipitate up to a third of acute heart failure (AHF) cases. We assessed the characteristics, initial management, and survival of AHF patients with (ACS-AHF) and without (nACS-AHF) concomitant ACS. METHODS AND RESULTS:Data from 620 AHF patients were analyzed in a prospect...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章,多中心研究

    doi:10.1016/j.cardfail.2014.07.008

    authors: Tarvasmäki T,Harjola VP,Nieminen MS,Siirilä-Waris K,Tolonen J,Tolppanen H,Lassus J,FINN-AKVA Study Group.

    更新日期:2014-10-01 00:00:00

  • Impaired glucose tolerance and insulin resistance in heart failure: underrecognized and undertreated?

    abstract:BACKGROUND:A link between diabetes mellitus (DM) and heart failure (HF) has been well-recognized for more than a century. HF is also closely linked to abnormal glucose regulation (AGR) and insulin resistance (IR) in patients without DM and, similarly, these conditions commonly coexist. In epidemiological studies, each ...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章,评审

    doi:10.1016/j.cardfail.2010.05.027

    authors: Mamas MA,Deaton C,Rutter MK,Yuille M,Williams SG,Ray SG,New J,Gibson JM,Neyses L

    更新日期:2010-09-01 00:00:00

  • 4-Hydroxy-2-nonenal induces calcium overload via the generation of reactive oxygen species in isolated rat cardiac myocytes.

    abstract:BACKGROUND:It has been reported that that the amount of 4-hydroxy-2-nonenal (HNE), which is a major lipid peroxidation product and a cytotoxic aldehyde, is increased in the human failing myocardium. This study was designed to determine whether HNE has a pro-oxidant effect in cardiac myocytes and whether HNE causes Ca(2...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2009.04.008

    authors: Nakamura K,Miura D,Kusano KF,Fujimoto Y,Sumita-Yoshikawa W,Fuke S,Nishii N,Nagase S,Hata Y,Morita H,Matsubara H,Ohe T,Ito H

    更新日期:2009-10-01 00:00:00

  • Relevance of water gymnastics in rehabilitation programs in patients with chronic heart failure or coronary artery disease with normal left ventricular function.

    abstract:BACKGROUND:Exercise training is included in cardiac rehabilitation programs to enhance physical capacity and cardiovascular function. Among the existing rehabilitation programs, exercises in water are increasingly prescribed. However, it has been questioned whether exercises in water are safe and relevant in patients w...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.cardfail.2011.04.008

    authors: Teffaha D,Mourot L,Vernochet P,Ounissi F,Regnard J,Monpère C,Dugué B

    更新日期:2011-08-01 00:00:00

  • Intravenous salt supplementation with low-dose furosemide for treatment of acute decompensated heart failure.

    abstract:BACKGROUND:Theoretically, salt supplementation should promote diuresis through increasing the glomerular filtration rate (GFR) during treatment of acute decompensated heart failure (ADHF) even with low-dose furosemide; however, there is little evidence to support this idea. METHODS AND RESULTS:This was a prospective, ...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.cardfail.2014.01.012

    authors: Okuhara Y,Hirotani S,Naito Y,Nakabo A,Iwasaku T,Eguchi A,Morisawa D,Ando T,Sawada H,Manabe E,Masuyama T

    更新日期:2014-05-01 00:00:00

  • Pioglitazone and heart failure: results from a controlled study in patients with type 2 diabetes mellitus and systolic dysfunction.

    abstract:BACKGROUND:Thiazolidinediones are associated with fluid retention, often interpreted as worsening cardiac function, limiting their use in patients with heart failure (HF). We compared the effects of pioglitazone and glyburide on cardiac function in patients with type 2 diabetes, systolic dysfunction, and New York Heart...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1016/j.cardfail.2008.02.007

    authors: Giles TD,Miller AB,Elkayam U,Bhattacharya M,Perez A

    更新日期:2008-08-01 00:00:00

  • Effect of left ventricular assist device placement on preexisting implantable cardioverter-defibrillator leads.

    abstract:BACKGROUND:The left ventricular assist device (LVAD) is a therapy for patients with end-stage heart failure, many of whom have a preexisting implantable cardioverter-defibrillator (ICD). We investigated whether the implantation of a LVAD affects ICD function. METHODS AND RESULTS:Patients implanted with a LVAD between ...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2009.12.003

    authors: Ambardekar AV,Lowery CM,Allen LA,Cannon AP,Cleveland JC Jr,Lindenfeld J,Brieke A,Sauer WH

    更新日期:2010-04-01 00:00:00

  • Sustained restoration of autonomic balance with long- but not short-acting metoprolol in patients with heart failure.

    abstract:BACKGROUND:The purpose of this study was to compare the effects of immediate-release (IR) metoprolol and extended-release (XL) metoprolol on measures of heart rate variability in chronic systolic heart failure patients. METHODS AND RESULTS:Thirteen metoprolol-treated heart failure patients were randomized to a 2-way c...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.cardfail.2005.12.002

    authors: Aquilante CL,Terra SG,Schofield RS,Pauly DF,Hatton PS,Binkley PF,Johnson JA

    更新日期:2006-04-01 00:00:00

  • Quality of care and hospital readmission in congestive heart failure: an explicit review process.

    abstract:BACKGROUND:The effect of hospital quality of care on hospital readmission for patients with congestive heart failure (CHF) has not been widely studied. METHODS AND RESULTS:We examined the effects of clinical factors, hospital quality of care, and cardiologist involvement on 3-month readmission rates in patients with C...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1054/jcaf.2001.28931

    authors: Polanczyk CA,Newton C,Dec GW,Di Salvo TG

    更新日期:2001-12-01 00:00:00

  • Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity.

    abstract:BACKGROUND:Cachexia in chronic heart failure carries a poor prognosis, but little is known about the influence of body mass on the prognosis of noncachectic heart failure patients. METHODS:We studied 589 consecutive chronic heart failure patients followed for at least a year, in whom there were accurate baseline data ...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1054/jcaf.2003.4

    authors: Davos CH,Doehner W,Rauchhaus M,Cicoira M,Francis DP,Coats AJ,Clark AL,Anker SD

    更新日期:2003-02-01 00:00:00

  • Influence of Donor Transmitted and Rapidly Progressive Coronary Vascular Disease on Long-Term Outcomes After Heart Transplantation: A Contemporary Intravascular Ultrasound Analysis.

    abstract:BACKGROUND:Donor-transmitted atherosclerosis (DTA) and rapidly progressive cardiac allograft vasculopathy (CAV) at 1 year are intravascular ultrasound (IVUS)-derived measures shown to predict adverse cardiovascular outcomes in the setting of early generation immunosuppressive agents. Given the paucity of data on the pr...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2020.12.012

    authors: Sperry BW,Qarajeh R,Omer MA,Brandt H,Safley D,Borkon AM,Everley MP,Fendler TJ,Khumri TM,Lawhorn SL,Magalski A,Nassif ME,Vodnala D,Kao AC,Austin BA

    更新日期:2021-01-20 00:00:00

  • Effects of lisinopril in patients with heart failure and chronic atrial fibrillation.

    abstract::Although atrial fibrillation is common in patients with heart failure, patients with atrial fibrillation are often excluded from congestive heart failure trials or are not analyzed separately. Consequently, while the effect of angiotensin-converting enzyme inhibitors in patients with sinus rhythm is well established, ...

    journal_title:Journal of cardiac failure

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/s1071-9164(05)80004-1

    authors: Van Den Berg MP,Crijns HJ,Van Veldhuisen DJ,Griep N,De Kam PJ,Lie KI

    更新日期:1995-12-01 00:00:00

  • Impact of Obesity on Volume Status in Patients With Ambulatory Chronic Heart Failure.

    abstract:BACKGROUND:Fluid overload is common in heart failure (HF) and obesity; however, the relationship between the extent of intravascular volume expansion and indices such as body mass index (BMI) in obese and non-obese patients with HF has not been defined to address the issue of a HF obesity phenotype. METHODS:Total bloo...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2019.09.010

    authors: Miller WL,Borlaug BA

    更新日期:2020-02-01 00:00:00

  • The association between high-dose diuretics and clinical stability in ambulatory chronic heart failure patients.

    abstract:OBJECTIVE:In chronic heart failure (HF), diuretic doses increase as the disease progresses, often after hospitalization for instability, and have been associated with worsening renal function and increased mortality. METHODS AND RESULTS:A prospective observational analysis of 183 patients in an advanced HF clinic stra...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2008.01.015

    authors: Mielniczuk LM,Tsang SW,Desai AS,Nohria A,Lewis EF,Fang JC,Baughman KL,Stevenson LW,Givertz MM

    更新日期:2008-06-01 00:00:00

  • The relationship between anemia, change in hematocrit over time and change in health status in patients with heart failure after myocardial infarction.

    abstract:BACKGROUND:Studies have identified anemia as a potential therapeutic target in patients with heart failure, with the goal of improving survival and health status. However, whether changes in hematocrit are associated with changes in health status is unknown. METHODS AND RESULTS:We studied 1382 patients with heart fail...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2007.09.009

    authors: Kosiborod M,Krumholz HM,Jones PG,Pitt B,Spertus JA

    更新日期:2008-02-01 00:00:00

  • Left Ventricular Deformation and Myocardial Fibrosis in Patients With Advanced Heart Failure Requiring Transplantation.

    abstract:PURPOSE:To evaluate potential relationships between different components of left ventricular (LV) function and histopathological evidence for myocardial fibrosis in patients undergoing heart transplantation. METHODS:The study population included patients with advanced heart failure, referred for an echocardiographic e...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2016.02.012

    authors: Cameli M,Mondillo S,Righini FM,Lisi M,Dokollari A,Lindqvist P,Maccherini M,Henein M

    更新日期:2016-11-01 00:00:00

  • The dog model of left ventricular remodeling after myocardial infarction.

    abstract:BACKGROUND:For over a century, the dog model has been used widely in research studying cardiovascular physiology pertinent to humans. It has been specially applied, over the past 2 decades, in research on the pathophysiology and treatment of left ventricular (LV) remodeling and heart failure. METHODS AND RESULTS:Becau...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章,评审

    doi:10.1054/jcaf.2002.129274

    authors: Jugdutt BI

    更新日期:2002-12-01 00:00:00

  • Right ventricular phenotypic characteristics in subjects with primary pulmonary hypertension or idiopathic dilated cardiomyopathy.

    abstract:BACKGROUND:Studies of animal models and human subjects with cardiomyopathies suggest that cardiac myocyte and ventricular chamber remodeling show distinct phenotypic characteristics that may be dependent on specific signaling pathways. METHODS AND RESULTS:In this study, we characterize right ventricular (RV) chamber s...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/s1071-9164(99)90024-6

    authors: Quaife RA,Lynch D,Badesch DB,Voelkel NF,Lowes BD,Robertson AD,Bristow MR

    更新日期:1999-03-01 00:00:00

  • High-intensity interval exercise in chronic heart failure: protocol optimization.

    abstract:BACKGROUND:There are little data on the optimization of high-intensity aerobic interval exercise (HIIE) protocols in patients with chronic heart failure (CHF). Therefore, we compared acute cardiopulmonary responses to 4 different HIIE protocols to identify the optimal one. METHODS AND RESULTS:Twenty men with stable sy...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.cardfail.2011.10.010

    authors: Meyer P,Normandin E,Gayda M,Billon G,Guiraud T,Bosquet L,Fortier A,Juneau M,White M,Nigam A

    更新日期:2012-02-01 00:00:00

  • Airway resistance in chronic heart failure measured by impulse oscillometry.

    abstract:BACKGROUND:Patients with chronic heart failure (CHF) complain of breathlessness and fatigue on exertion, have reduced peak oxygen consumption (pV(O(2))), and an increased ventilatory response to exercise (V(E)/V(CO(2)) slope). These limitations correlate with abnormalities of spirometry (forced expiratory volume in 1 s...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1054/jcaf.2002.126916

    authors: Witte KK,Morice A,Clark AL,Cleland JG

    更新日期:2002-08-01 00:00:00

  • Searching for evidence: Refractory questions in advanced heart failure.

    abstract:BACKGROUND:Despite ample data from randomized clinical trials (RCTs), the management of advanced heart failure (HF) varies greatly. We examined the most common refractory questions arising in routine inpatient management of advanced HF. METHODS:From the inpatient HF service at 1 hospital, we prospectively recorded cli...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2003.10.006

    authors: Shah MR,Stevenson LW

    更新日期:2004-06-01 00:00:00

  • Biomarker-guided therapies in heart failure: a forum for unified strategies.

    abstract::The complexity of standard medical treatment for heart failure is growing, and such therapy typically involves 5 or more different medications. Given these pressures, there is increasing interest in harnessing cardiovascular biomarkers for clinical application to more effectively guide diagnosis, risk stratification, ...

    journal_title:Journal of cardiac failure

    pub_type:

    doi:10.1016/j.cardfail.2013.05.012

    authors: Fiuzat M,O'Connor CM,Gueyffier F,Mascette AM,Geller NL,Mebazaa A,Voors AA,Adams KF,Piña IL,Neyses L,Muntendam P,Felker GM,Pitt B,Zannad F,Bristow MR

    更新日期:2013-08-01 00:00:00

  • Plasma corin levels provide minimal prognostic utility incremental to natriuretic peptides in chronic systolic heart failure.

    abstract:BACKGROUND:Corin is a serine protease that cleaves pro-atrial and pro-B-type natriuretic peptides into biologically active hormones. The relationship between soluble plasma corin levels, plasma natriuretic peptide levels, myocardial structure and performance, and long-term clinical outcomes in the setting of chronic sy...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2010.03.010

    authors: Shrestha K,Troughton RW,Borowski AG,Yandle TG,Richards AM,Klein AL,Tang WH

    更新日期:2010-08-01 00:00:00

  • Patient-reported economic burden and the health status of heart failure patients.

    abstract:BACKGROUND:Heart failure (HF) guidelines recommend treatment with multiple medications to improve survival, functioning, and quality of life. Yet, HF treatments can be costly, resulting in significant economic burden for some patients. To date, there are few data on the impact of patients' perceived difficulties in aff...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2006.03.004

    authors: Conard MW,Heidenreich P,Rumsfeld JS,Weintraub WS,Spertus J,Cardiovascular Outcomes Research Consortium.

    更新日期:2006-06-01 00:00:00

  • Potential effects of digoxin on long-term renal and clinical outcomes in chronic heart failure.

    abstract:BACKGROUND:Digitalis glycosides are known to improve the hemodynamic and neurohormonal perturbations that contribute to heart failure (HF)-induced renal dysfunction (RD). The objective of this study was to determine if randomization to digoxin is associated with improvement in renal function (IRF) and to evaluate if pa...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.cardfail.2013.03.002

    authors: Testani JM,Brisco MA,Tang WH,Kimmel SE,Tiku-Owens A,Forfia PR,Coca SG

    更新日期:2013-05-01 00:00:00

  • Extending the boundaries of cardiac resynchronization therapy: efficacy in atrial fibrillation, New York heart association class II, and narrow QRS heart failure patients.

    abstract:BACKGROUND:Large-scale clinical trials have demonstrated the benefits of cardiac resynchronization therapy (CRT) in patients with New York Heart Association (NYHA) Class III/IV heart failure, systolic left ventricular dysfunction, and a wide QRS. However, additional patient groups may also benefit from CRT. METHODS AN...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章,meta分析

    doi:10.1016/j.cardfail.2009.12.018

    authors: Wein S,Voskoboinik A,Wein L,Billah B,Krum H

    更新日期:2010-05-01 00:00:00

  • Tolerability to beta-blocker therapy among heart failure patients in clinical practice.

    abstract:BACKGROUND:Although beta-blockers were well-tolerated by heart failure (HF) patients in clinical trials, tolerability of these drugs in a general population of HF patients is not well-described. METHODS:We studied a total of 308 encounters with beta-blockers therapy in 268 ambulatory HF patients. Side effects and freq...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章,多中心研究

    doi:10.1054/jcaf.2003.34

    authors: Butler J,Khadim G,Belue R,Chomsky D,Dittus RS,Griffin M,Wilson JR

    更新日期:2003-06-01 00:00:00

  • HFSA 2006 Comprehensive Heart Failure Practice Guideline.

    abstract::Heart failure (HF) is a syndrome characterized by high mortality, frequent hospitalization, reduced quality of life, and a complex therapeutic regimen. Knowledge about HF is accumulating so rapidly that individual clinicians may be unable to readily and adequately synthesize new information into effective strategies o...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章,实务指引

    doi:10.1016/j.cardfail.2005.11.005

    authors: Heart Failure Society Of America

    更新日期:2006-02-01 00:00:00

  • Baseline Characteristics Predict the Presence of Amyloid on Endomyocardial Biopsy.

    abstract:BACKGROUND:Recent studies have suggested a high prevalence of cardiac amyloidosis (CAm) in heart failure (HF) patients. CAm might be underdiagnosed owing to low clinical suspicion. METHODS AND RESULTS:We performed retrospective analysis of 259 patients with HF and ejection fraction (EF) ≥50% referred for endomyocardia...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2016.12.006

    authors: Ton VK,Bhonsale A,Gilotra NA,Halushka MK,Steenbergen C,Almansa J,Brown E,Tedford RJ,Wittstein I,Sharma K,Russell SD,Judge DP

    更新日期:2017-04-01 00:00:00

  • Electroanatomic Properties of the Myocardium Predict Response to CD34+ Cell Therapy in Patients With Ischemic and Nonischemic Heart Failure.

    abstract:BACKGROUND:We investigated a correlation between electromechanical properties of the myocardium and response to CD34+ cell therapy in patients with chronic heart failure. METHODS AND RESULTS:We enrolled 40 patients with ischemic cardiomyopathy (ICM) and 40 with nonischemic dilated cardiomyopathy (DCM). All patients we...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2016.08.002

    authors: Zemljic G,Poglajen G,Sever M,Cukjati M,Frljak S,Androcec V,Cernelc P,Haddad F,Vrtovec B

    更新日期:2017-02-01 00:00:00